In a significant breakthrough for reproductive biology, a Yale-led research team has successfully mapped the molecular architecture of a naturally…
Read More
Amazon Bio Discovery Accelerates Drug Development, Cuts MSK Antibody Design from a Year to Weeks
Amazon Web Services (AWS) has unveiled Amazon Bio Discovery, a groundbreaking application designed to dramatically accelerate the drug discovery process,…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
SEATTLE, WA – Amazon Web Services (AWS) has unveiled Amazon Bio Discovery, a groundbreaking application poised to dramatically accelerate drug…
Read More
Groundbreaking Nanodisc Platform Unveils Unprecedented Insights into Viral Protein-Antibody Interactions, Promising Accelerated Vaccine Development
A pioneering scientific breakthrough has emerged from Scripps Research in California, USA, in collaboration with IAVI (New York, USA) and…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
The core of Amazon Bio Discovery lies in its ability to route AI-designed antibody candidates directly to leading DNA Synthesis…
Read More
Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies
Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies Roche, a global pharmaceutical giant,…
Read More
Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline
Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…
Read More
Gilead Acquires Antibody-Drug Conjugate Pioneer Tubulis for Up to $5 Billion, Bolstering Oncology Pipeline
Sixteen months after forging a strategic collaboration, Gilead Sciences has announced its definitive agreement to acquire German biotechnology firm Tubulis,…
Read More
The Rise of Antibody-Drug Conjugates: Precision Oncology’s Evolving Frontier
Antibody-drug conjugates (ADCs) represent a significant leap forward in targeted cancer therapy, a sophisticated class of drugs that marries the…
Read More
The Crucial Role of Payload Linker Innovation in the Rapidly Expanding Antibody-Drug Conjugate Market
Combining the targeted precision of monoclonal antibodies with the potent destructive power of cytotoxic payloads, Antibody-Drug Conjugates (ADCs) represent a…
Read MoreYOU MAY HAVE MISSED
